SEC EDGAR CompanyFacts fact · reporting period
Zander Therapeutics, Inc: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
$1.381M{"amount": 1380911, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}- Entity
- Zander Therapeutics, Inc
- Metric
- cashflow_financing
- Period
- 2017-07-01 – 2018-06-30
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:35:01.979409+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001718644/cashflow-financing/2018-06-30 (CIK, metric, reporting date)History
- supersedes {"amount": 1566100, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001607062-18-000292)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.